Correlation Between Fate Therapeutics and EXACT Sciences
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and EXACT Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and EXACT Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and EXACT Sciences, you can compare the effects of market volatilities on Fate Therapeutics and EXACT Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of EXACT Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and EXACT Sciences.
Diversification Opportunities for Fate Therapeutics and EXACT Sciences
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Fate and EXACT is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and EXACT Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EXACT Sciences and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with EXACT Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EXACT Sciences has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and EXACT Sciences go up and down completely randomly.
Pair Corralation between Fate Therapeutics and EXACT Sciences
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the EXACT Sciences. In addition to that, Fate Therapeutics is 1.48 times more volatile than EXACT Sciences. It trades about -0.06 of its total potential returns per unit of risk. EXACT Sciences is currently generating about 0.07 per unit of volatility. If you would invest 4,449 in EXACT Sciences on September 25, 2024 and sell it today you would earn a total of 1,361 from holding EXACT Sciences or generate 30.59% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. EXACT Sciences
Performance |
Timeline |
Fate Therapeutics |
EXACT Sciences |
Fate Therapeutics and EXACT Sciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and EXACT Sciences
The main advantage of trading using opposite Fate Therapeutics and EXACT Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, EXACT Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXACT Sciences will offset losses from the drop in EXACT Sciences' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
EXACT Sciences vs. Fate Therapeutics | EXACT Sciences vs. Caribou Biosciences | EXACT Sciences vs. Karyopharm Therapeutics | EXACT Sciences vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |